Treatment Strategy for Stage III-N2 Non-Small Cell Lung Cancer: The Role of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors

1,274
Total downloads
5,080
Total views and downloads

Articles

REVIEW

Published on 27 Mar 2024

A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer

Madeleine B. Hopson
Sawsan Rashdan

A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer

doi 10.3389/fonc.2024.1373388

1,831 views
1 citation

ORIGINAL RESEARCH

Published on 18 Oct 2023

The journey of stage III and IV non-small cell lung cancer patients in the Brazilian private healthcare system: a retrospective study

Erica R. Cerqueira
Paula M. Batista
Milena F. Almeida
Maria A. C. Rego
Ana C. P. Ribeiro-Pereira
Fernando Alencar
Roberta A. Fernandes
Aknar F. C. Calabrich
Gustavo Schvartsman

The journey of stage III and IV non-small cell lung cancer patients in the Brazilian private healthcare system: a retrospective study

doi 10.3389/fonc.2023.1257003

1,785 views

Share on

Frontiers in Oncology

Frontiers in Oncology

Thoracic Oncology

Impact

5,080Topic views
3,183Article views
1,274Article downloads